The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 02, 2025

Filed:

Oct. 01, 2024
Applicants:

Mohammed A. Baradwan, Jeddah, SA;

Abdelsattar M. Omar, Jeddah, SA;

Mahmoud A. Elfaky, Jeddah, SA;

Moustafa E. El-araby, Cairo Governorate, EG;

Sameh H. Soror, Cairo Governorate, EG;

Inventors:

Mohammed A. Baradwan, Jeddah, SA;

Abdelsattar M. Omar, Jeddah, SA;

Mahmoud A. Elfaky, Jeddah, SA;

Moustafa E. El-Araby, Cairo Governorate, EG;

Sameh H. Soror, Cairo Governorate, EG;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 233/90 (2006.01); A61K 31/4164 (2006.01); A61K 31/4439 (2006.01); A61K 45/06 (2006.01); C07D 401/12 (2006.01);
U.S. Cl.
CPC ...
C07D 233/90 (2013.01); A61K 31/4164 (2013.01); A61K 31/4439 (2013.01); A61K 45/06 (2013.01); C07D 401/12 (2013.01);
Abstract

Chronic hepatitis C is a global health problem affecting large number of people and leads to mortalities and morbidities. In this invention, new compounds belonging to 2-substituted-1H-imidazole-4-carboxamide derivatives (Formula I) intended for use in the treatment of hepatitis C are disclosed. The compounds interfere with the important viral peptide NS4A co-enzyme function. The described art includes chemical synthesis, spectral confirmation and binding assays with NS3 protein.


Find Patent Forward Citations

Loading…